Table 4—

Prediction of newly developed microvascular complications subdivided into three skin autofluorescence (AF) groups

Microvascular complicationn*Skin AF <2.35 AU2.35 ≤ Skin AF <3.00 AUSkin AF ≥3.00 AU
Retinopathy70815/241 (6.2)18/251 (7.2)28/216 (13.0)
Neuropathy66211/219 (5.0)27/247 (10.9)28/196 (14.3)
(Micro)albuminuria65718/225 (8.0)31/253 (12.3)38/179 (21.2)
Any43123/161 (14.3)41/167 (24.6)45/103 (43.7)
  • Data are n (%) of newly developed microvascular complications of subgroups compared with the group who did not develop a microvascular complication.

  • *

    * Patients who did not have a complication at baseline. Subgroups of skin AF are tertiles rounded to a practical level.